Related Experiment Videos
Genetics of antiphospholipid syndrome
Tetsuya Horita1, Joan T Merrill
1Clinical Pharmacology Research program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA. horitat@omrf.ouhsc.edu
Current Rheumatology Reports
|November 6, 2004
Summary
Genetic factors contribute to antiphospholipid syndrome (APS), an autoimmune disorder. Identifying specific genes requires further research due to APS complexity and multifactorial nature.
Area of Science:
- Immunology
- Genetics
- Rheumatology
Background:
- Antiphospholipid syndrome (APS) is an autoimmune disorder.
- APS is characterized by thrombosis and/or pregnancy morbidity with antiphospholipid antibodies (aPL).
- Genetic susceptibility is implicated in APS, with known human leukocyte antigen associations.
Purpose of the Study:
- To explore the genetic underpinnings of antiphospholipid syndrome (APS).
- To investigate the role of genetic factors in APS susceptibility and pathophysiology.
- To highlight the need for genetic studies in understanding APS.
Main Methods:
- Review of existing literature on APS genetics.
- Discussion of genetic associations, including human leukocyte antigen and beta-2-glycoprotein I.
- Emphasis on the need for genome-wide linkage analysis and large cohort studies.
Main Results:
- Genetic factors are believed to influence APS susceptibility.
- The genetics of beta-2-glycoprotein I, a key antigen, have been studied.
- Additional genetic risk factors for thrombosis in APS patients are under discussion.
Conclusions:
- The specific genes involved in APS remain unidentified due to disease heterogeneity and multifactorial pathophysiology.
- Further large-scale genetic studies are crucial for advancing the understanding of APS.
- Identifying genetic factors could improve APS diagnosis and management.